Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-01-31 @ 1:49 PM
Study NCT ID:
NCT03124459
Status:
TERMINATED
Last Update Posted:
2022-09-26
First Post:
2017-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Sponsor:
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Organization: